Upper Urinary Tract Transitional Cell Carcinoma: Is There a Best?

被引:6
作者
Gunay, Levent Mert [1 ]
Akdogan, Bulent [2 ]
Koni, Artan [2 ]
Inci, Kubilay [2 ]
Bilen, Cenk Yucel [2 ]
Ozen, Haluk [2 ]
机构
[1] Mersin Ozel Sistem Cerrahi Tip Merkezi, Mersin, Turkey
[2] Hacettepe Univ, Sch Med, Dept Urol, Ankara, Turkey
关键词
Nephroureterectomy; Recurrence; Transitional cell carcinoma; Upper urinary tract; BLADDER-CANCER; RISK-FACTORS; RADICAL NEPHROURETERECTOMY; ADJUVANT CHEMOTHERAPY; PREDICT; TUMORS;
D O I
10.1016/j.clgc.2012.08.009
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
This study retrospectively reports a 22-year single-center Turkish experience with 101 upper urinary tract (UUT) transitional cell carcinoma (TCC) cases focusing on risk factors affecting recurrences, which may help in decision making in management of these patients. It points to the importance of female sex and smoking history for bladder recurrence as independent risk factors. This article also presents experience with several treatment choices. Background: This study aimed to determine the prognostic and risk factors for bladder and systemic recurrence after nephroureterectomy (NU) in patients with upper urinary tract (UUT) transitional cell carcinoma (TCC). Patients and Methods: Data from 101 patients with nonmetastatic UUT TCC who underwent NU between 1987 and 2009 were retrospectively evaluated. Kaplan-Meier curves for sex, age, anemia, smoking, stone disease, or history of bladder tumor, primary tumor localization, multiplicity, and disease stage and grade were constructed to predict 5-year recurrence-free survival (RFS). Multivariate Cox regression analysis was used to identify independent risk factors for recurrence. Results: Bladder, distant, and local recurrence rates at a mean of 56.19 +/- 5.30 months after NU were 38.5%, 19.8%, and 7.9%, respectively. Univariate analysis showed that among the patients with bladder recurrence, female patients had significantly lower 5-year RFS than did male patients (34.7% +/- 0.13% vs. 62.4% +/- 0.06%, P = .038); however multivariate analysis showed that both female sex and a history of smoking were independent risk factors for bladder recurrence (odds ratio [OR], 4.22; 95% confidence interval [CI], 1.56-11.4; P = 0.005 and OR, 2.84; 95% CI, 1.1-7.4; P = .032, respectively). Univariate analysis showed that among the patients with local and distant recurrence, anemia, a positive history of bladder tumor, localization of the primary tumor, multiplicity, disease stage, and tumor grade significantly affected RFS, whereas primary tumor stage and grade were the only independent risk factors for 5-year RFS (OR, 4.48; 95% CI, 1.45-13.79; P = .009 and OR, 5.82; 95% CI, 2.08-16.26; P = .001, respectively). Conclusion: Female sex and a history of smoking were independent risk factors for bladder recurrence after NU. Such patients should be monitored closely using cystoscopy and urine cytologic examination. Invasive and higher grade UUT TCC was associated with worse local or systemic RFS. Clinical Genitourinary Cancer, Vol. 11, No. 1, 39-44 (C) 2013 Elsevier Inc. All rights reserved.
引用
收藏
页码:39 / 44
页数:6
相关论文
共 22 条
[1]   Chromosome 20q13.2 gain may predict intravesical recurrence after nephroureterectomy in upper urinary tract urothelial tumors [J].
Akao, Jumpei ;
Matsuyama, Hideyasu ;
Yamamoto, Yoshiaki ;
Sasaki, Kohsuke ;
Naito, Katsusuke .
CLINICAL CANCER RESEARCH, 2006, 12 (23) :7004-7008
[2]   Prognostic significance of bladder tumor history and tumor location in upper tract transitional cell carcinoma [J].
Akdogan, Bulent ;
Dogan, Hasan Serkan ;
Eskicorapci, Saadettin Yilmaz ;
Sahin, Ahmet ;
Erkan, Ilhan ;
Ozen, Haluk .
JOURNAL OF UROLOGY, 2006, 176 (01) :48-52
[3]  
Azemar MD, 2009, UROL ONCOL, V29, P130
[4]   Adjuvant chemotherapy with paclitaxel and carboplatin in patients with advanced carcinoma of the upper urinary tract: A study by the Hellenic Cooperative Oncology Group [J].
Bamias, A ;
Deliveliotis, C ;
Fountzilas, G ;
Gika, D ;
Anagnostopoulos, A ;
Zorzou, MP ;
Kastritis, E ;
Constantinides, C ;
Kosmidis, P ;
Dimopoulos, MA .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (11) :2150-2154
[5]   Prognostic Factors in Patients With Advanced Transitional Cell Carcinoma of the Urothelial Tract Experiencing Treatment Failure With Platinum-Containing Regimens [J].
Bellmunt, Joaquim ;
Choueiri, Toni K. ;
Fougeray, Ronan ;
Schutz, Fabio A. B. ;
Salhi, Yacine ;
Winquist, Eric ;
Culine, Stephane ;
von der Maase, Hans ;
Vaughn, David J. ;
Rosenberg, Jonathan E. .
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (11) :1850-1855
[6]   Risk factors for the development of bladder cancer after upper tract urothelial cancer [J].
Hisataki, T ;
Miyao, N ;
Masumori, N ;
Takahashi, A ;
Sasai, M ;
Yanase, M ;
Itoh, N ;
Tsukamoto, T .
UROLOGY, 2000, 55 (05) :663-667
[7]  
HUBEN RP, 1988, CANCER-AM CANCER SOC, V62, P2016, DOI 10.1002/1097-0142(19881101)62:9<2016::AID-CNCR2820620924>3.0.CO
[8]  
2-G
[9]   Identification of Immunohistochemical Factors That Predict the Synchronous or Metachronous Development of Bladder Tumors in Patients with Upper Urinary Tract Tumors [J].
Joung, Jae Young ;
Yang, Seung Ok ;
Jeong, In Gab ;
Han, Kyung Seok ;
Seo, Ho Kyung ;
Chung, Jinsoo ;
Park, Weon Seo ;
Lee, Geon Kook ;
Lee, Kang Hyun .
UROLOGIA INTERNATIONALIS, 2008, 81 (03) :306-311
[10]   Laparoscopic Radical Nephroureterectomy: A Multicenter Analysis in Japan [J].
Kamihira, Osamu ;
Hattori, Ryohei ;
Yamaguchi, Akito ;
Kawa, Gen ;
Ogawa, Osamu ;
Habuchi, Tomonori ;
Kawauchi, Akihiro ;
Uozumi, Jiro ;
Yokoi, Shigeaki ;
Tsujihata, Masao ;
Hasui, Yoshihiro ;
Miyakoda, Keiko ;
Tada, Harue ;
Ono, Yoshinari ;
Naito, Seiji .
EUROPEAN UROLOGY, 2009, 55 (06) :1397-1409